16th Annual Meeting of the Alpe Adria Association of Cardiology

General information
aac2008@sicardio.org

Meeting venue
Adriatic Resort & Convention Center St. Bernardin
Grand Hotel Bernardin
hoteli.bernardin@siol.net
http://www.h-bernardin.si/

Information about registration
Cankarjev dom
Congress and Cultural Centre Ljubljana
Ms. Mojca Juvančič
registration@cd-cc.si

Hotel accommodation
Ms. Darja Kovačevič
Grand Hotel Bernardin
booking@h-bernardin.si

	Hall A

9.00-11.00	SESSION 6. HEART FAILURE - 2 Chairmen: Robert H.G. Schwinger (Weiden, Germany), Mitja Lainščak (Golnik, Slovenia)
9.00	Pathophysiology of heart failure - evidence for treatment? Robert H.G. Schwinger (Weiden, Germany)
9.15	New Therapies for Heart Failure Robert E. Hobbs (Cleveland, OH, USA)
9.30	Salto mortale in cardiac cachexia - why is fatter possibility better? Stefan D, Anker (Berlin, Germany)
9.45	Gender differences in clinical profile, new quality markers and in-hospital mortality of chronic heart failure Alexander Klabnik (Slovakia)
10.00	Sudden death in heart failure Antoni Bayes de Luna (Barcelona, Spain)
10.15	Improvement of physical performance and quality of life in patients with heart failure Janez Poles, Slovenia
10.30	Discussion

11.30-13.30	SESSION 8. HEART FAILURE - 3 Michel Komajda (Paris, France), Jindrich Špinar (Brno, Czech Republic)
11.30	Clinical reality of heart failure treatment in Europe Mitja Lainščak (Golnik, Slovenia)
11.45	Factors that could predict patient response to CRT Alessandro Proclemer (Udine, Italy)
12.00	Our experiences with CRT at the Ljubljana University Hospital Igor Zupan (Ljubljana, Slovenia)
12.15	Treatment of acute heart failure – do we need new drugs? Jindrich Špinar (Brno, Czech Republic)
12.30	Left ventricular assist devices in acute and chronic heart failure Igor Gregorič (Houston, Texas, USA)
12.45	The Role of Heart Transplantation in Treating Advanced Heart Failure in Slovenia Bojan Vrtovec, Slovenia
13.00	Discussion

15.00-16.30	SESSION 10. INTERVENTIONAL CARDIOLOGY Chairmen: Marko Noc (Ljubljana, Slovenia), Petr Widimski (Prague, Czech Republic)
15.00	PCI after CABG - rescue role reversal? Maja Strozzi (Zagreb, Croatia)
15.20	Acute target vessel failure Igor Kranjec (Ljubljana, Slovenia)
15.35	Non-responsiveness to clopidogrel - an update Shlomi Matetzky (Tel Aviv, Israel)
15.50	MSCT and MRI an an aid for interventional cardiology Sandro Salvi (Trieste, Italy)
16.00	Discussion

17.00-19.00	SESSION 11. CARDIAC IMAGING Chairmen: Istvan Preda (Budapest, Hungary), Vinzenz Hombach (Ulm, Germany)
17.00	Diagnostic potential of cardiac MRI in patients with acute chest pain Vinzenz Hombach (Ulm, Germany)
17.15	MRI and myocardial perfusion Pavel Berden (Ljubljana, Slovenia)
17.30	Qualitative assessment of coronary angiograms Petr Widimsky (Prague, Czech Republic)
17.45	First Hungarian experiences with multidetector computer tomography in the diagnosis of coronary heart disease Istvan Preda (Budapest, Hungary)
18.00	The comparison of the analysis of coronary artery disease – CT angiography vs. coronary angiography Branko Cvetičanin^1,2, Marjeta Zorc¹, Nataša Černič^1,2, Marko Noč^1,3 (¹MC Medicor Izola, ²Splo#353;na bolni#353;nica Izola, ³University Medical Centre Ljubljana, Slovenia)
18.15	Evaluation of Noncompaction Cardiomyopathy by Real-time Three-Dimensional Echocardiography Attila Nemes¹, Ashraf M Anwar², Kadir Caliskan², Osama I Soliman², Marcel L Geleijnse², Bas M Van Dalen², Folkert J Ten Cate² (Szeged, Hungary¹, Rotterdam, Netherlands²)
18.30	Discussion

	Hall B
9.00-11.00	SESSION 7. PHARMACOTHERAPY AND ELECTRICAL TREATMENT IN ATRIAL FIBRILLATION Symposium supported by Biotronik GmbH Chairmen: Berndt Lüderitz (Bonn, Germany), Stefan G. Spitzer (Dresden, Germany)
9.00	Historical perspectives - General remarks Konrad Steinbach (Vienna, Austria)
9.20	New concepts in understanding antiarrhythmic effects Johannes Brachmann (Coburg, Germany)
9.40	Rate and Rhythm control - where are we now, what is to come Bernd-Dieter Gonska (Karlsruhe, Germany)
10.00	Advanced Catheter-Ablation Ernst G. Vester (Düsseldorf, Germany)
10.20	Hypertension and Arrhythmias Wolfgang Motz (Karlsburg, Germany)
10.40	Discussion

11.30-12.30	Why and how can we survive better with omega-3 PUFA? Satellite Symposium sponsored by Solvay Pharma
11.30	Cardiovascular risk and the omega-3 index Clemens von Schacky (Munich, Germany)
11.50	Can cardiovascular patients satisfy their needs for omega-3 PUFAs with nutrition? Dan Gaita (Timisoara, Romania)
12.05	International guidelines on fish consumption, n-3 PUFA and CV disease Zlatko Fras (Ljubljana, Slovenia)
12.20	Discussion

12.30-13.30	Beta blockers in patients with heart failure: do we have all the answers? Satellite Symposium sponsored by MerckSerono Chairpersons: Irena Keber (Ljubljana, Slovenia), Stefan D. Anker (Berlin, Germany)
12.30	CIBIS III - is the egg and chicken dilemma in heart failure resolved? Stefan D. Anker (Berlin, Germany)
12.50	Making the right beta-blocker choice in the treatment of systolic heart failure? John M. Cruickshank (Manchester, United Kingdom)
13.10	CIBIS-ELD: the missing link for the beta blockers use in clinical practice Mitja Lainščak (Golnik, Slovenia)
13.20	Discussion

15.00-16.00	SESSION 9. CARDIOMYOPATHIES Chairmen: Fulvio Camerini (Trieste, Italy), Miklos Csanady (Szeged, Hungary)
15.00	Cardiomyopathies 2008 - clinical and genetic approach Fulvio Camerini (Trieste, Italy)
15.15	Long Term Outcome of Dilated Cardiomyopathy: A Large Cohort from the Heart Muscle Disease Registry of Trieste Gianfranco Sinagra¹, A Di Lenarda¹, M Merlo¹, G Barbati², M Zecchin¹, G Sabbadini¹ (Trieste, Italy¹, Torino, Italy²)
15.30	Differential diagnosis of hypertrophic cardiomyopathy Sanjay Sharma (London, Great Britain)
15.45	The genetics of hypertrophic cardiomyopathy: where do we stand? Robert Sepp (Szeged, Hungary)
16.00	The role of endomycardial biopsy in the decision of surgical treatment of primary dilated cardiomyopathy Marjeta Zorc^1,2, Janez Kirbiš¹, Danijel Petrovič^1,2, Ruda Zorc-Pleskovič^1,2, Ninoslav Radovanović¹ (¹MC Medicor Izola, ²Institute of Histology and Embryology, Medical Faculty, University Ljubljana)
16.15	Discussion

17.00-18.30	How to improve cardiovascular prevention? Satellite Symposium sponsored by Krka (www.krka.biz) Chairman: Pavel Poredoš (Ljubljana, Slovenia)
	Welcome address Elizabeta Suhadolc (Krka d.d., Novo mesto, Slovenia)
	The effect of cardiovascular risk management on cardiovascular events in PAD patients: The PID-PAB study Aleš Blinc (Ljubljana, Slovenia)
	Clinical reality of coronary heart disease prevention Zlatko Fras (Ljubljana, Slovenia)
	How effectively can we delay CV events in multiple risk factor patients? Jindrich Špinar (Brno, Czech Republic)
	Contribution of Krka's drugs to cardiovascular prevention Breda Barbič Žagar (Krka d.d., Novo mesto, Slovenia)
	Discussion

	Hall C
9.00-11.00	FREE COMMUNICATIONS 3 - RISK FACTORS Each oral presentation is scheduled for 8 minutes, followed with 3 minutes of discussion. Chairmen: Janez Tasič (Celje, Slovenia), Dan Gaita (Timisioara, Romania)
	Dislipidemia As a Risk Factor in Appearance of Coronary Disease in Postmenopausal Women D Nesic, Todorka Savić, Nenad Veljković (Niš, Serbia)
	Oxiditative Stress and Dislipidemia in Diabetes - Its Cumulative Influence on the Appearance of Coronary Disease Todorka Savić, D Nesic, Boris Đinđić (Niš, Serbia)
	Disturbance in the Composition of Lipoprotein Particles and Chronical Inflammation As Pathogenetic Factors in the Development of Coronary Heart Disease Todorka Savić, Boris Đinđić, Vladmila Bojanić, Nenad Veljković (Niš, Serbia)
	Polymorphisms in the Promoter Region of the Basic Fibroblast Growth Factor Gene Are Not Associated With Myocardial Infarction in the Slovene Population With Type 2 Diabetes Stojan Kariž¹, Miha Krkovič², Joško Osredkar², Metka Zorc¹, Daniel Petrovič¹ (Izola, Slovenia¹, Ljubljana, Slovenia²)
	The MCP-1 Genotype Influences the Level of hsCRP in Patients with Coronary Artery Disease. Peter Penz¹, Jan Lietava¹, Maria Bucova¹, M Bernadic¹, Thomas Buckingham¹, M Petrek² (Bratislava, Slovakia¹, Olomouc, Czech Republic²)
	Could Measurement of Arterial Stiffness Provide Better Approach in Risk Assessment than the Conventional Risk Factor-Based Stratification (SCORE)? Béla Benczúr¹, Renáta Böcskei², Ferenc Molnár², Miklós Illyés Phd² (Szolnok, Hungary¹, Budapest, Hungary²)
	History of Cardiovascular Diseases, Cardiovascular Risk Score and Cognitive Function in Older Adults in Central and Eastern Europe Martin Bobak¹, Elizabeth A Webb¹, Ruzena Kubinova², Andrzej Pajak³, Sofia Malyutina⁴ (London, United Kingdom¹, Prague, Czech Republic², Krakow, Poland³, Novosibirsk, Russian Federation⁴)
	Cerebrovascular Reactivity to L-arginine - A Method for Evaluation of Cerebral Endothelial Function Janja Pretnar-oblak (Ljubljana, Slovenia)

11.30-13.30	FREE COMMUNICATIONS 4 - CORONARY HEART DISEASE Each oral presentation is scheduled for 8 minutes, followed with 3 minutes of discussion. Chairpersons: Andreja Sinkovič (Maribor, Slovenia), Daroslav Ivaškovič (Šmarješke Toplice)
	Surgical Revascularization of the Heart after Treatment with Iloprost in Diffuse Distal Coronary Artery Disease Anton Lobnik, Marko Bombek, Vojko Kanič, Juš Kšela, Gorazd Košir (Maribor, Slovenia)
	Role of Brain Natriuretic Peptide in Stable Coronary Heart Disease Ludvik Puklavec, Zlatko Pehnec, Mitja Topalovic (Maribor, Slovenia)
	Comparison of Intracoronary and Systemic Levels of Inflammation Markers in Patients with Coronary Artery Disease. Simona Kirbiš, Urška D Breskvar, Miso Sabovic, Igor Zupan (Ljubljana, Slovenia)
	Unstable Angina in Patients with STEMI Treated by PCI as a Protection Factor of Short-term Survival Krystyna Prymusova, Jiri Parenica, Petr Kala, Martin Poloczek, Lubomir Elbl, Martin Tesak, Lenka Kubkova, Jan Manousek, Ondrej Toman, Ludmila Dostalova, Jindrich Spinar (Brno, Czech Republic)
	Gender Differences in Early Stent Thrombosis Vojko Kanic, Andreja Sinkovic, Anton Lobnik, Damijan Vokac (Maribor, Slovenia)
	Different Mechanisms of Restenosis After Drug Eluting Stent Implantataion Zsolt Kőszegi, István Varga, Miklós Szokol, Tibor Szűk, Kornél Toma, Gusztáv Vajda, Ferenc Győry, István édes (Debrecen, Hungary)
	Predictive Power of the Logistic Euroscore for Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Vojko Kanic¹, Gorazd Voga², Igor Balevski¹, Franjo Naji¹ (Maribor, Slovenia¹, Celje, Slovenia²)
	The Incidence of MACE after Discontinuation of Clopidogrel in Patients with Implanted Drug Eluting Stent D Dobovšek, T Butenko, Igor Zupan (Ljubljana, Slovenia)

15.00-16.30	FREE COMMUNICATIONS 5 - MISCELLANEOUS Each oral presentation is scheduled for 8 minutes, followed with 3 minutes of discussion. Chairmen: Andrea Podzeck – Schweighofer (Vienna, Austria), Mirko Bombek (Maribor, Slovenia)
	The Resistance to Aspirin and Clopidogrel Detected by Multiplate in a Patient with Recurrent Coronary Stent Thrombosis Bosko Skoric, Ivan Skorak, Davor Lovric, Kristina Narancic Skoric, Jure Samardzic, Maja Strozzi, Davor Milicic (Zagreb, Croatia)
	Effect of Complex Interventional Treatment - Laser, Stenting and Stem Cells - on Short and Long Term Patency in Aortoiliac Diseases Claudia Matei, Theodora Benedek, Monica Chitu, Melinda Struczuy, Alexandru Sarbu, Imre Benedek (Targu-mures, Romania)
	Monitoring of Antiplatelet Therapy by Multiple Electrode Aggregometry (Multiplate) in Patients with Stable Coronary Artery Disease Davor Milicic, Daniel Lovric, Kristina Maric, Kristina Narancic Skoric, Jure Samardzic, Jadranka Sertic, Ivan Skorak, Maja Strozzi, Bosko Skoric (Zagreb, Croatia)
	Trimetazidine Shortens QTc Interval in Patients With Ischemic Heart Failure Gregor Zemljič¹, Matjaž Bunc¹, Bojan Vrtovec¹, Rajko Radovancevic² (Ljubljana, Slovenia¹, Houston, USA²)
	Initial Experience with New Biodegradable PFO Closure Device (Biostar) Nataša Černič¹, Metka Zorc¹, Saibal Kar², Marko Noč¹ (Izola, Slovenia¹, Los Angeles, USA²)
	Outcome of Patients with Acute Myocarditis During One-Year period Andreja Cerne (Ljubljana, Slovenia)
	What is Missing from the Guidelines: the Wellens’ – Syndrome Ernő Kis, István Domonyai, Mihály Józan, Jilling Iván, Lajos Papp (Szekszárd, Hungary)
	Concommitant Use of Antihypertensive and Psychopharmacological Therapy in Out-Ward Patients in General Practitioners is Associated with Decreased Blood Pressure Jan Lietava, Viera Kosmalova, Peter Turek, Viera Husarova, Jan Pecenak (Bratislava, Slovakia)

17.00-18.30	FREE COMMUNICATIONS 6 - ACUTE CORONARY SYNDROMES Each oral presentation is scheduled for 8 minutes, followed with 3 minutes of discussion. Chairmen: Igor Zupan (Ljubljana, Slovenia), Vojko Kanič (Maribor, Slovenia)
	Mortality Reduction During a Regional Registry of Acute Coronary Syndromes on a Target Population of 1 Million Inhabitants – 4 Years Results Alexandru I Sarbu-pop, Theodora Benedek, Claudia Matei, Melinda Struczuy, Istvan Benedek Jr, Monica Chitu, Szillard Madaras, Imre Benedek (Targu Mures, Romania)
	Strategy for Treatment of Myocardial Infarction in Macedonia Vladimir Kotevski, Hristo Pejkov (Skopje, The former Yugoslav Republic of Macedonia)
	Our Experience with Intracoronary Transplantation of Autologous Bone Marrow Stem Cells in Patients with Acute Myocardial Infarction Hristo Pejkov, Vladimir Kotevski, Sasko Kedev, Antonio Georgiev (Skopje, The former Yugoslav Republic of Macedonia)
	Admission Blood Glucose Level As a Risk Factor in Patients After Acute Myocardial Infarction Radka Adamkova, S Janousek, A Tomasek, J Tumova, Z Cermakova, J Spinar (Brno, Czech Republic)
	Admission Haemoglobin A1c Levels Predict Adverse Events in Patients with Acute Coronary Syndrome without ST Segment Elevation Andrej Pernat¹, Marko Kmet², Igor Kranjec¹ (Ljubljana, Slovenia¹, Novo Mesto, Slovenia²)
	Acute Coronary Syndromes in Patients under 40 - Our Experiences in Middle Slovak Institute of Cardiovascular Diseases, Banska Bystrica, Slovakia Roman Margóczy (Banska Bystrica, Slovakia)
	Independent Predictors of 6-Month Mortality in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI) Andreja Sinkovič, Metka Koren (Maribor, Slovenia)